<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03163485</url>
  </required_header>
  <id_info>
    <org_study_id>UKER-EPIMI-RNA-C</org_study_id>
    <nct_id>NCT03163485</nct_id>
  </id_info>
  <brief_title>Hybrid Device DIALYTRODE for Multimodal Neuro-monitoring of Patients With Brain Injury and Status Epilepticus</brief_title>
  <official_title>Prospective, Open Label, Multi-centre, Controlled Phase 2a Clinical Trial to Investigate the Safety and Diagnostic Performance of the Multifunctional Hybrid Device Combining a Micro-dialysis Probe With an Intra-cortical Depth Electrode (DIALYTRODE) for Short Time Continuous Multimodal Neuro-monitoring of NICU Patients With Severe Brain Injury and Suspected Status Epilepticus in Surface EEG</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Commission</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal College of Surgeons, Ireland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Philipps University Marburg Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dixi Medical</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ARTTIC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This clinical trial evaluates the safety and diagnostic performance of a newly developed
      combined catheter that will be implanted into the brain of patients with severe brain injury
      for short time (up to 28 days) monitoring of the electric activity and the metabolism of
      brain tissue at risk. Ten patients will be monitored with the new device and seven patients
      will be monitored by intracerebral probes according to standard treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Early detection of nonconvulsive status epilepticus (NCSE) in patients treated in
      neurological intensive care unit (NICU) is essential, as delayed treatment can aggravate
      their clinical situation and worsen the outcome. In this study in intensive care patients
      with severe brain injury due to malignant middle cerebral artery (MCA) infarction,
      subarachnoidal hemorrhage (SAH) or intracerebral hemorrhage (ICH) with suspected status
      epilepticus in the surface EEG the hybrid catheter Dialytrode will be implanted in the
      cortical brain tissue by neurosurgeons for short time continuous bedside multimodal
      neuro-monitoring. Dialytrode combines a microdialysis catheter and depth EEG probe. Ten
      subjects will be monitored by Dialytrode and an additional (intracranial pressure (ICP)
      probe. Subjects with an clinical indication of an external ventricular drain (EVD) or
      cerebral microdialysis alone serve as control. The monitoring period with the device is
      limited to the microdialysis phase with a maximum of 28 days. Subjects will be followed up
      for 7 days after end of intracerebral monitoring.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 25, 2018</start_date>
  <completion_date type="Anticipated">July 25, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 25, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of adverse device effects (ADE) and serious adverse device effects (SADE)</measure>
    <time_frame>Up to day 7±2 after removal of IMD or the single control devices respectively</time_frame>
    <description>Number of adverse device effects (ADE) and serious adverse device effects (SADE) from Baseline (day 1) to day 7+/-2 after removal of the investigational medical device (IMD) or the control devices respectively) in the intervention group compared to control</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">17</enrollment>
  <condition>Epilepsy</condition>
  <condition>Brain Injuries</condition>
  <arm_group>
    <arm_group_label>Dialytrode</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multimodal neuro-monitoring by dialytrode (investigational medical device)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Either EVD and/or micro-dialysis according to standard treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dialytrode</intervention_name>
    <description>Multimodal neuromonitoring by intracerebral depth EEG recording combined with microdialysis for the sampling of cerebrospinal fluid during EEG recording</description>
    <arm_group_label>Dialytrode</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard treatment</intervention_name>
    <description>Monitoring of intracranial pressure by EVD and/or multimodal neuromonitoring by microdialysis for sampling of cerebrospinal fluid</description>
    <arm_group_label>Standard treatment</arm_group_label>
    <other_name>EVD and/or microdialysis catheter alone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Clinical condition requiring treatment in NICU

          2. MCA OR Subarachnoidal haemorrhage (SAH) OR Intracerebral haemorrhage (ICH)

          3. Given indication of EVD with or without multimodal monitoring by micro-dialysis OR
             Given indication of multimodal monitoring by micro-dialysis and continuous depth
             EEG-monitoring due to (a) suspected SE in surface EEG (e.g. rhythmic pattern) or (b)
             refractory status epilepticus (RSE) in surface EEG or (c) an unclear situation of not
             waking up even though sedation is reduced OR Suspected SE without acute brain injury

        Exclusion Criteria (main criteria):

          -  Subject receiving anticoagulants in therapeutic dose

          -  Bleeding disorder

          -  Known contraindications for EEG depth electrodes or microdialysis probes

          -  Presence of an infectious lesion of skin (limited to the scalp)

          -  Presence of general contraindications for any surgical intervention

          -  Sepsis or acute severe bacterial infection

          -  Fragile bones of the skull

          -  Severe organ failure or medical conditions displaying a contraindication for
             participating

          -  Pregnant or nursing woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hajo Hamer, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Erlangen Neurologische Klinik</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hajo Hamer, MD PhD</last_name>
    <phone>+49 +9131</phone>
    <phone_ext>39116</phone_ext>
    <email>hajo.hamer@uk-erlangen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Felix Rosenow, MD PhD</last_name>
    <phone>+49 +69 6301</phone>
    <phone_ext>7466</phone_ext>
    <email>rosenow@med.uni-frankfurt.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hajo Hamer, Prof.Dr.med.</last_name>
      <phone>+49 +9131 85</phone>
      <phone_ext>39116</phone_ext>
      <email>hajo.hamer@uk-erlangen.de</email>
    </contact>
    <investigator>
      <last_name>Hajo Hamer, Prof.Dr.med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt Epilepsiezentrum Rhein-Main</name>
      <address>
        <city>Frankfurt am Main</city>
        <zip>60528</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Felix Rosenow, Prof.Dr.med.</last_name>
      <phone>+0049 +69 6301</phone>
      <phone_ext>7466</phone_ext>
      <email>rosenow@med.uni-frankfurt.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2017</study_first_submitted>
  <study_first_submitted_qc>May 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2017</study_first_posted>
  <last_update_submitted>October 27, 2017</last_update_submitted>
  <last_update_submitted_qc>October 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>epilepsy</keyword>
  <keyword>multimodal neuromonitoring</keyword>
  <keyword>depth EEG</keyword>
  <keyword>microdialysis</keyword>
  <keyword>brain injury</keyword>
  <keyword>brain tissue at risk</keyword>
  <keyword>NCSE</keyword>
  <keyword>short time monitoring</keyword>
  <keyword>neurologic ICU</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Status Epilepticus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

